Upload 8 files

added_tokens.json

@@ -0,0 +1,1258 @@
+{
+  "180 Life Sciences Corp.": 51431,
+  "2invest AG": 51019,
+  "2seventy bio, Inc.": 51564,
+  "3-D Matrix, Ltd.": 50795,
+  "3D Global Biotech Inc.": 51547,
+  "3SBio Inc.": 50695,
+  "4D Molecular Therapeutics, Inc.": 51136,
+  "4D pharma plc": 51098,
+  "4SC AG": 50415,
+  "4basebio PLC": 51562,
+  "89bio, Inc.": 51494,
+  "ABIONYX Pharma SA": 50687,
+  "ABIVAX Société Anonyme": 51099,
+  "ABL Bio Inc.": 51263,
+  "ABVC BioPharma, Inc.": 51244,
+  "AC Immune SA": 50679,
+  "ACADIA Pharmaceuticals Inc.": 50471,
+  "ACRO Biomedical Co., Ltd.": 51262,
+  "ADC Therapeutics SA": 51002,
+  "ADMA Biologics, Inc.": 50824,
+  "AEON Biopharma, Inc.": 51073,
+  "AFC Agro Biotech Limited": 51074,
+  "AGC Biologics S.p.A.": 50675,
+  "AIM ImmunoTech Inc.": 50403,
+  "ALTEOGEN Inc.": 50978,
+  "ALX Oncology Holdings Inc.": 51185,
+  "ARCA biopharma, Inc.": 50712,
+  "ARS Pharmaceuticals, Inc.": 51430,
+  "ASLAN Pharmaceuticals Limited": 51321,
+  "AVEO Pharmaceuticals, Inc.": 50529,
+  "AVITA Medical, Inc.": 50563,
+  "AVROBIO, Inc.": 51245,
+  "AXIM Biotechnologies, Inc.": 50948,
+  "Aadi Bioscience, Inc.": 51332,
+  "AbbVie Inc.": 50983,
+  "Abbisko Cayman Limited": 51592,
+  "Abcam plc": 50623,
+  "Abeona Therapeutics Inc.": 50446,
+  "Abera Bioscience AB": 51107,
+  "Abliva AB (publ)": 50696,
+  "Absci Corporation": 51120,
+  "Acceleron Pharma Inc.": 50611,
+  "Acelyrin, Inc.": 51558,
+  "Acepodia, Inc.": 51487,
+  "Aceragen, Inc.": 50379,
+  "Achieve Life Sciences, Inc.": 51312,
+  "Achiko AG": 51467,
+  "Achilles Therapeutics plc": 51297,
+  "Acorda Therapeutics, Inc.": 50359,
+  "AcouSort AB (publ)": 51014,
+  "Acrivon Therapeutics, Inc.": 51508,
+  "Acrobiosystems Co.,Ltd.": 51568,
+  "Acticor Biotech SAS": 51164,
+  "Actinium Pharmaceuticals, Inc.": 50594,
+  "Actinogen Medical Limited": 50763,
+  "Active Biotech AB (publ)": 50490,
+  "Acumen Pharmaceuticals, Inc.": 50605,
+  "Acurx Pharmaceuticals, Inc.": 51391,
+  "AdAlta Limited": 50852,
+  "Adagene Inc.": 50943,
+  "Adamas Pharmaceuticals, Inc.": 50820,
+  "Adaptimmune Therapeutics plc": 50923,
+  "Addex Therapeutics Ltd": 50535,
+  "Adhera Therapeutics, Inc.": 51156,
+  "Adicet Bio, Inc.": 51205,
+  "Adimmune Corporation": 50744,
+  "Aditxt, Inc.": 51380,
+  "Adocia SA": 50788,
+  "Advanced Proteome Therapeutics Corporation": 50738,
+  "Advaxis, Inc.": 50595,
+  "Adverum Biotechnologies, Inc.": 51016,
+  "AegirBio AB (publ)": 51511,
+  "Aeglea BioTherapeutics, Inc.": 51090,
+  "Aerovate Therapeutics, Inc.": 51504,
+  "Aeterna Zentaris Inc.": 50459,
+  "Affimed N.V.": 50486,
+  "AgeX Therapeutics, Inc.": 51342,
+  "Agenus Inc.": 50457,
+  "Agios Pharmaceuticals, Inc.": 50807,
+  "Aileron Therapeutics, Inc.": 50674,
+  "Aimmune Therapeutics, Inc.": 51062,
+  "Ainos, Inc.": 50448,
+  "Akari Therapeutics, Plc": 51197,
+  "Akebia Therapeutics, Inc.": 50766,
+  "Akero Therapeutics, Inc.": 51411,
+  "Akeso, Inc.": 51513,
+  "Akouos, Inc.": 51363,
+  "Alaunos Therapeutics, Inc.": 50645,
+  "Albert Labs International Corp.": 51563,
+  "Albireo Pharma, Inc.": 50791,
+  "Aldeyra Therapeutics, Inc.": 50808,
+  "Alector, Inc.": 51078,
+  "Alexion Pharmaceuticals, Inc.": 50443,
+  "Aligos Therapeutics, Inc.": 51423,
+  "Alkermes plc": 50361,
+  "Allakos Inc.": 51036,
+  "Allarity Therapeutics, Inc.": 51040,
+  "Allena Pharmaceuticals, Inc.": 50985,
+  "Allied Biotech Corporation": 50831,
+  "Alligator Bioscience AB (publ)": 50547,
+  "AlloVir, Inc.": 51287,
+  "Allogene Therapeutics, Inc.": 51390,
+  "Alnylam Pharmaceuticals, Inc.": 50537,
+  "Alpha Cognition Inc.": 51210,
+  "Alphamab Oncology": 51437,
+  "Alpine Immune Sciences, Inc.": 51168,
+  "Alterity Therapeutics Limited": 50531,
+  "Altimmune, Inc.": 50570,
+  "Alvotech": 51550,
+  "Alzamend Neuro, Inc.": 51279,
+  "Alzinova AB (publ)": 51003,
+  "Amarin Corporation plc": 50456,
+  "Ambrx Biopharma Inc.": 51583,
+  "America Great Health": 51083,
+  "American CryoStem Corporation": 50965,
+  "American Films, Inc.": 50545,
+  "Amgen Inc.": 50362,
+  "Amicus Therapeutics, Inc.": 50582,
+  "Amniotics AB (publ)": 51480,
+  "Amoy Diagnostics Co., Ltd.": 51097,
+  "Amplia Therapeutics Limited": 50705,
+  "AnGes, Inc.": 50597,
+  "AnaptysBio, Inc.": 50724,
+  "Anavex Life Sciences Corp.": 50656,
+  "Angiolab, Inc.": 50927,
+  "Anhui Anke Biotechnology (Group) Co., Ltd.": 50869,
+  "Anika Therapeutics, Inc.": 50439,
+  "Anixa Biosciences, Inc.": 50431,
+  "Annexon, Inc.": 51153,
+  "Annovis Bio, Inc.": 51475,
+  "Anti-Microbial Savior BioteQ Co., Ltd": 51597,
+  "Apellis Pharmaceuticals, Inc.": 50898,
+  "Apexigen, Inc.": 50917,
+  "Apogee Therapeutics, Inc.": 51613,
+  "Apollomics, Inc.": 51286,
+  "Aposense Ltd.": 50465,
+  "Applied Genetic Technologies Corporation": 50584,
+  "Applied Molecular Transport Inc.": 51178,
+  "Applied Therapeutics, Inc.": 51395,
+  "Aprea Therapeutics, Inc.": 51251,
+  "AprilBio Co.,Ltd.": 51468,
+  "Aptahem AB (publ)": 51152,
+  "Aptamer Group plc": 51415,
+  "Aptevo Therapeutics Inc.": 51257,
+  "Aptinyx Inc.": 51265,
+  "Aptorum Group Limited": 51093,
+  "Aptose Biosciences Inc.": 50406,
+  "Apures Co., Ltd.": 51490,
+  "AquaBounty Technologies, Inc.": 50474,
+  "Aravive, Inc.": 50845,
+  "Arbutus Biopharma Corporation": 50750,
+  "Arcellx, Inc.": 51206,
+  "Arctic Bioscience AS": 51572,
+  "ArcticZymes Technologies ASA": 50655,
+  "Arcturus Therapeutics Holdings Inc.": 51048,
+  "Arcus Biosciences, Inc.": 51243,
+  "Arcutis Biotherapeutics, Inc.": 51378,
+  "Ardelyx, Inc.": 50841,
+  "Arecor Therapeutics plc": 50784,
+  "Arena Pharmaceuticals, Inc.": 50363,
+  "Aridis Pharmaceuticals, Inc.": 50752,
+  "Armata Pharmaceuticals, Inc.": 50880,
+  "Aroa Biosurgery Limited": 50847,
+  "Arrowhead Pharmaceuticals, Inc.": 50425,
+  "Arterra Bioscience S.p.A.": 51495,
+  "Ascelia Pharma AB (publ)": 50616,
+  "Ascendis Pharma A/S": 50787,
+  "Ascentage Pharma Group International": 51474,
+  "Ascletis Pharma Inc.": 51418,
+  "Asia Green Biotechnology Corp.": 51404,
+  "Assembly Biosciences, Inc.": 50884,
+  "Astria Therapeutics, Inc.": 50892,
+  "Atara Biotherapeutics, Inc.": 51075,
+  "Athenex, Inc.": 50691,
+  "Athersys, Inc.": 50364,
+  "Atossa Therapeutics, Inc.": 50890,
+  "Atreca, Inc.": 50981,
+  "Aura Biosciences, Inc.": 50889,
+  "Aurinia Pharmaceuticals Inc.": 50492,
+  "Autolus Therapeutics plc": 51400,
+  "Avacta Group Plc": 50686,
+  "Avalo Therapeutics, Inc.": 50991,
+  "Avid Bioservices, Inc.": 50424,
+  "Avidity Biosciences, Inc.": 51101,
+  "Awakn Life Sciences Corp.": 51526,
+  "Axcella Health Inc.": 50952,
+  "Ayala Pharmaceuticals, Inc.": 51369,
+  "BBS-Bioactive Bone Substitutes Oyj": 51026,
+  "BCAL Diagnostics Limited": 51270,
+  "BELLUS Health Inc.": 50404,
+  "BGI Genomics Co., Ltd.": 51228,
+  "BIO-FD&C Co.,Ltd.": 51272,
+  "BIOTON S.A.": 50676,
+  "BLIRT S.A.": 50944,
+  "BNC Korea Co., Ltd.": 51150,
+  "BSF Enterprise Plc": 51451,
+  "Basilea Pharmaceutica AG": 50516,
+  "Bavarian Nordic A/S": 50590,
+  "Beam Therapeutics Inc.": 51403,
+  "BeiGene, Ltd.": 50932,
+  "Beijing Kawin Technology Share-Holding Co., Ltd.": 50855,
+  "Beijing Leadman Biochemistry Co.,Ltd.": 50914,
+  "Beijing Luzhu Biotechnology Co., Ltd.": 51333,
+  "Beijing SL Pharmaceutical Co., Ltd.": 50673,
+  "Beijing Science Sun Pharmaceutical Co., Ltd.": 51118,
+  "Beijing Tiantan Biological Products Co., Ltd.": 50628,
+  "Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.": 50768,
+  "Bellerophon Therapeutics, Inc.": 51103,
+  "Bellicum Pharmaceuticals, Inc.": 50730,
+  "Benitec Biopharma Inc.": 50566,
+  "BerGenBio ASA": 50902,
+  "Beroni Group Limited": 51306,
+  "Berry Genomics Co.,Ltd": 51018,
+  "BeyondSpring Inc.": 51302,
+  "Bharat Immunologicals & Biologicals Corporation Limited": 50658,
+  "BiVictriX Therapeutics Plc": 51314,
+  "Bicycle Therapeutics plc": 50870,
+  "Bio Preventive Medicine Corp.": 51268,
+  "Bio-Path Holdings, Inc.": 50772,
+  "Bio-Thera Solutions, Ltd.": 51438,
+  "BioArctic AB (publ)": 50688,
+  "BioAtla, Inc.": 50896,
+  "BioCardia, Inc.": 50626,
+  "BioCryst Pharmaceuticals, Inc.": 50365,
+  "BioGaia AB (publ)": 50557,
+  "BioGend Therapeutics Co., Ltd.": 51379,
+  "BioInvent International AB (publ)": 50418,
+  "BioLineRx Ltd.": 50571,
+  "BioMarin Pharmaceutical Inc.": 50366,
+  "BioNTech SE": 50825,
+  "BioNote, Inc.": 50886,
+  "BioPorto A/S": 50642,
+  "BioRestorative Therapies, Inc.": 50840,
+  "BioVie Inc.": 51063,
+  "BioXcel Therapeutics, Inc.": 51364,
+  "Bioasis Technologies Inc.": 50780,
+  "Bioceltix S.A.": 51453,
+  "Biocept, Inc.": 50508,
+  "Biocon Limited": 50606,
+  "Biocure Technology Inc.": 50871,
+  "Biocytogen Pharmaceuticals (Beijing) Co., Ltd.": 51612,
+  "Biodexa Pharmaceuticals Plc": 51148,
+  "Bioerg Spólka Akcyjna": 50950,
+  "Biogen Inc.": 50380,
+  "Biohaven Pharmaceutical Holding Company Ltd.": 51089,
+  "Bioleaders Corporation": 50867,
+  "BiomX Inc.": 51334,
+  "Biomea Fusion, Inc.": 51556,
+  "Biomm S.A.": 50665,
+  "Bioneer Corporation": 50634,
+  "Bionomics Limited": 50551,
+  "Biora Therapeutics, Inc.": 51095,
+  "Bioray Biotech Co., Ltd": 51422,
+  "Biosergen AB": 50725,
+  "Biosino Bio-Technology and Science Incorporation": 50709,
+  "Biotest Aktiengesellschaft": 50564,
+  "Biotron Limited": 50587,
+  "Bioventix PLC": 50689,
+  "Biovica International AB (publ)": 51087,
+  "Bioxytran, Inc.": 51425,
+  "Black Diamond Therapeutics, Inc.": 51328,
+  "Blau Farmacêutica S.A.": 50811,
+  "Bloomage BioTechnology Corporation Limited": 50814,
+  "Blueprint Medicines Corporation": 50958,
+  "Bolt Biotherapeutics, Inc.": 51182,
+  "Bone Biologics Corporation": 50883,
+  "Bone Therapeutics SA": 50860,
+  "Bonesupport Holding AB (publ)": 51331,
+  "Bonus BioGroup Ltd.": 50972,
+  "Brainstorm Cell Therapeutics Inc.": 50612,
+  "BriaCell Therapeutics Corp.": 51114,
+  "Bridge Biotherapeutics, Inc.": 51249,
+  "BridgeBio Pharma, Inc.": 51307,
+  "Bright Minds Biosciences Inc.": 51546,
+  "BrightPath Biotherapeutics Co., Ltd.": 50827,
+  "Brii Biosciences Limited": 51405,
+  "Burning Rock Biotech Limited": 51204,
+  "Burzynski Research Institute, Inc.": 50540,
+  "C4 Therapeutics, Inc.": 51233,
+  "CANbridge Pharmaceuticals Inc.": 51589,
+  "CARsgen Therapeutics Holdings Limited": 51582,
+  "CASI Pharmaceuticals, Inc.": 50445,
+  "CEL-SCI Corporation": 50429,
+  "CK Life Sciences Int'l., (Holdings) Inc.": 50586,
+  "COMPASS Pathways plc": 51421,
+  "CRISPR Therapeutics AG": 51115,
+  "CSL Limited": 50489,
+  "CStone Pharmaceuticals": 51455,
+  "CTI BioPharma Corp.": 50368,
+  "Cabaletta Bio, Inc.": 51436,
+  "Calidi Biotherapeutics, Inc.": 51413,
+  "Calithera Biosciences, Inc.": 50911,
+  "Can-Fite BioPharma Ltd.": 50470,
+  "CanBas Co., Ltd.": 50707,
+  "Candel Therapeutics, Inc.": 50771,
+  "Cantargia AB (publ)": 50946,
+  "Capricor Therapeutics, Inc.": 50729,
+  "Capstone Therapeutics Corp.": 50441,
+  "Cardiff Oncology, Inc.": 50636,
+  "CareDx, Inc": 50629,
+  "Caribou Biosciences, Inc.": 51134,
+  "Carisma Therapeutics, Inc.": 51337,
+  "Carmell Therapeutics Corporation": 50887,
+  "Catalyst Biosciences, Inc.": 50602,
+  "Catalyst Pharmaceuticals, Inc.": 50572,
+  "Celcuity Inc.": 51094,
+  "Cell Biotech Co., Ltd.": 50509,
+  "Cell Source, Inc.": 51086,
+  "CellSeed Inc.": 50574,
+  "Celldex Therapeutics, Inc.": 50625,
+  "Cellectar Biosciences, Inc.": 50773,
+  "Cellectis S.A.": 50505,
+  "Celltrion, Inc.": 50528,
+  "Cellular Biomedicine Group, Inc.": 51030,
+  "Celularity Inc.": 51295,
+  "Celyad Oncology SA": 50754,
+  "Centessa Pharmaceuticals plc": 51570,
+  "Century Therapeutics, Inc.": 51479,
+  "Cereno Scientific AB (publ)": 51022,
+  "Cerevel Therapeutics Holdings, Inc.": 51432,
+  "Cha Vaccine Research Institute Co., Ltd.": 51310,
+  "Changchun BCHT Biotechnology Co.": 50959,
+  "Checkmate Pharmaceuticals, Inc.": 51180,
+  "Checkpoint Therapeutics, Inc.": 51172,
+  "ChemoCentryx, Inc.": 50497,
+  "Chemomab Therapeutics Ltd.": 51239,
+  "Chempartner Pharmatech Co., Ltd.": 50931,
+  "Chengdu Kanghua Biological Products Co., Ltd.": 50804,
+  "Chengdu Olymvax Biopharmaceuticals Inc.": 51284,
+  "Chimeric Therapeutics Limited": 51542,
+  "Chimerix, Inc.": 50550,
+  "China Regenerative Medicine International Limited": 50589,
+  "China Resources Boya Bio-pharmaceutical Group Co., Ltd.": 50995,
+  "Chinook Therapeutics, Inc.": 51489,
+  "Chongqing Zhifei Biological Products Co., Ltd.": 50857,
+  "Cibus, Inc.": 50949,
+  "Cidara Therapeutics, Inc.": 51124,
+  "Cizzle Biotechnology Holdings Plc": 50722,
+  "Clal Biotechnology Industries Ltd.": 50462,
+  "Clene Inc.": 51269,
+  "Clinuvel Pharmaceuticals Limited": 50580,
+  "Clover Biopharmaceuticals, Ltd.": 51584,
+  "Clovis Oncology, Inc.": 50843,
+  "Codiak BioSciences, Inc.": 51208,
+  "Coeptis Therapeutics Holdings, Inc.": 51441,
+  "Cogent Biosciences, Inc.": 51528,
+  "CohBar, Inc.": 50968,
+  "Coherus BioSciences, Inc.": 51012,
+  "CollPlant Biotechnologies Ltd.": 50708,
+  "CombiGene AB (publ)": 51135,
+  "Comera Life Sciences Holdings, Inc.": 51611,
+  "Compass Therapeutics, Inc.": 51122,
+  "Concert Pharmaceuticals, Inc.": 50721,
+  "Connect Biopharma Holdings Limited": 51573,
+  "ContraFect Corporation": 50920,
+  "Corbus Pharmaceuticals Holdings, Inc.": 51091,
+  "Corium, Inc.": 50704,
+  "Corvus Pharmaceuticals, Inc.": 51151,
+  "Cotinga Pharmaceuticals Inc.": 50715,
+  "Covalon Technologies Ltd.": 50624,
+  "Coya Therapeutics, Inc.": 51561,
+  "Creative Medical Technology Holdings, Inc.": 51246,
+  "Crinetics Pharmaceuticals, Inc.": 51155,
+  "Cue Biopharma, Inc.": 51317,
+  "Cullinan Oncology, Inc.": 51356,
+  "Cuorips Inc.": 51417,
+  "Curacle Co., Ltd.": 51461,
+  "Curasight A/S": 51529,
+  "Curative Biotechnology, Inc.": 50800,
+  "CureVac N.V.": 50668,
+  "Curis, Inc.": 50369,
+  "Cyclacel Pharmaceuticals, Inc.": 50408,
+  "Cyclerion Therapeutics, Inc.": 51398,
+  "Cyclo Therapeutics, Inc.": 50541,
+  "Cynata Therapeutics Limited": 50777,
+  "Cyteir Therapeutics, Inc.": 51169,
+  "CytoDyn Inc.": 50630,
+  "Cytokinetics, Incorporated": 50370,
+  "CytomX Therapeutics, Inc.": 50851,
+  "Cyxone AB (publ)": 51254,
+  "D. Western Therapeutics Institute, Inc.": 50828,
+  "DBV Technologies S.A.": 50583,
+  "DNA Link, Inc.": 50874,
+  "Daan Gene Co., Ltd.": 50641,
+  "Daesung Microbiological Labs. Co., Ltd.": 50622,
+  "Day One Biopharmaceuticals, Inc.": 51571,
+  "Decibel Therapeutics, Inc.": 51209,
+  "Deciphera Pharmaceuticals, Inc.": 50599,
+  "Defence Therapeutics Inc.": 51345,
+  "Delta-Fly Pharma, Inc.": 50997,
+  "Denali Therapeutics Inc.": 51184,
+  "DermTech, Inc.": 50476,
+  "Dermata Therapeutics, Inc.": 51166,
+  "Design Therapeutics, Inc.": 51477,
+  "Destiny Pharma plc": 50419,
+  "Devyser Diagnostics AB (publ)": 51554,
+  "Dextech Medical AB": 51034,
+  "DiNonA Inc.": 50693,
+  "DiaMedica Therapeutics Inc.": 50561,
+  "Diagonal Bio AB (publ)": 51581,
+  "Diamyd Medical AB (publ)": 50813,
+  "Dicerna Pharmaceuticals, Inc.": 50783,
+  "Diffusion Pharmaceuticals Inc.": 50607,
+  "Dimerix Limited": 50692,
+  "Disc Medicine, Inc.": 51497,
+  "Diurnal Group plc": 50706,
+  "Dizal (Jiangsu) Pharmaceutical Co., Ltd.": 51366,
+  "Dominari Holdings Inc.": 50428,
+  "Dragon Life Science Holdings Group, Inc.": 50604,
+  "Dyadic International, Inc.": 50559,
+  "Dynavax Technologies Corporation": 50460,
+  "Dyne Therapeutics, Inc.": 51464,
+  "EOM Pharmaceuticals Holdings, Inc.": 51609,
+  "EQRx, Inc.": 51506,
+  "ESSA Pharma Inc.": 51141,
+  "EXACT Therapeutics AS": 51426,
+  "Eagle Pharmaceuticals, Inc.": 50552,
+  "Edesa Biotech, Inc.": 51207,
+  "Editas Medicine, Inc.": 51082,
+  "Egetis Therapeutics AB (publ)": 50747,
+  "Eiger BioPharmaceuticals, Inc.": 50830,
+  "Eledon Pharmaceuticals, Inc.": 50866,
+  "Elevation Oncology, Inc.": 51534,
+  "Elicera Therapeutics AB (publ)": 51559,
+  "Elicio Therapeutics, Inc.": 51020,
+  "Eliem Therapeutics, Inc.": 51457,
+  "Emergent BioSolutions Inc.": 50657,
+  "Emergent Health Corp": 50781,
+  "Enanta Pharmaceuticals, Inc.": 50442,
+  "Endonovo Therapeutics, Inc.": 51001,
+  "Energenesis Biomedical CO.,LTD.": 51350,
+  "Enimmune corporation": 51224,
+  "Enlivex Therapeutics Ltd.": 50878,
+  "Ensol Biosciences Inc.": 50954,
+  "Ensysce Biosciences, Inc.": 50826,
+  "Entasis Therapeutics Holdings Inc.": 51393,
+  "Entera Bio Ltd.": 50901,
+  "Entheon Biomedical Corp.": 51522,
+  "Entrada Therapeutics, Inc.": 51445,
+  "Enzon Pharmaceuticals, Inc.": 50435,
+  "Epigenomics AG": 50416,
+  "Epizyme, Inc.": 50838,
+  "Equillium, Inc.": 51420,
+  "Erasca, Inc.": 51444,
+  "Essex Bio-Technology Limited": 50598,
+  "EuBiologics Co., Ltd.": 51060,
+  "Eupraxia Pharmaceuticals Inc.": 51037,
+  "Eurobio Scientific Société anonyme": 50412,
+  "Eurocine Vaccines AB (publ)": 50514,
+  "European Institute of Science AB (publ)": 50484,
+  "Eutilex.Co.,Ltd": 51216,
+  "Evaxion Biotech A/S": 51223,
+  "Evelo Biosciences, Inc.": 51258,
+  "Ever Supreme Bio Technology Co., Ltd": 51384,
+  "Everest Medicines Limited": 51367,
+  "Evgen Pharma plc": 50875,
+  "Evogene Ltd.": 50549,
+  "Evolutionary Genomics, Inc.": 51121,
+  "Exact Sciences Corporation": 50373,
+  "Exagen Inc.": 50603,
+  "Exelixis, Inc.": 50374,
+  "Exicure, Inc.": 50876,
+  "Exopharm Limited": 51433,
+  "ExpreS2ion Biotech Holding AB (publ)": 50924,
+  "Exscientia plc": 51296,
+  "F-star Therapeutics, Inc.": 51514,
+  "Faron Pharmaceuticals Oy": 50765,
+  "Fate Therapeutics, Inc.": 50782,
+  "Fennec Pharmaceuticals Inc.": 50518,
+  "FibroGen, Inc.": 50375,
+  "Finch Therapeutics Group, Inc.": 51229,
+  "First Wave BioPharma, Inc.": 51112,
+  "Flexion Therapeutics, Inc.": 50853,
+  "FluoGuide A/S": 51459,
+  "Foghorn Therapeutics Inc.": 51354,
+  "Forma Therapeutics Holdings, Inc.": 50999,
+  "Formycon AG": 50879,
+  "Forte Biosciences, Inc.": 51443,
+  "Fortress Biotech, Inc.": 50861,
+  "Forward Pharma A/S": 50728,
+  "Foundation Medicine, Inc.": 50893,
+  "Freeline Therapeutics Holdings plc": 51230,
+  "Frequency Therapeutics, Inc.": 51313,
+  "Fresh Tracks Therapeutics, Inc.": 50915,
+  "Frontier Biotechnologies Inc.": 50976,
+  "FunPep Company Limited": 51222,
+  "Fusion Pharmaceuticals Inc.": 51323,
+  "G1 Therapeutics, Inc.": 50979,
+  "GC Biopharma Corp.": 50553,
+  "GENINUS Inc.": 51473,
+  "GI Innovation, Inc.": 51525,
+  "GNI Group Ltd.": 50713,
+  "GT Biopharma, Inc.": 50434,
+  "Gain Therapeutics, Inc.": 51385,
+  "Galapagos NV": 50524,
+  "Galectin Therapeutics Inc.": 50500,
+  "Galecto, Inc.": 50994,
+  "Galera Therapeutics, Inc.": 51035,
+  "Galmed Pharmaceuticals Ltd.": 50929,
+  "Gamida Cell Ltd.": 50464,
+  "Gan & Lee Pharmaceuticals.": 50897,
+  "GeNeuro SA": 50815,
+  "Gelesis Holdings, Inc.": 50751,
+  "Gemina Laboratories Ltd.": 51578,
+  "Gemini Therapeutics, Inc.": 51261,
+  "GenMont Biotech Incorporation": 50659,
+  "GenSight Biologics S.A.": 51049,
+  "Gene Biotherapeutics, Inc.": 50697,
+  "GeneOne Life Science, Inc.": 50621,
+  "GeneTether Therapeutics Inc.": 51604,
+  "GeneThera, Inc.": 50527,
+  "Genelux Corporation": 50639,
+  "Genenta Science S.p.A.": 51163,
+  "General Biologicals Corporation": 50667,
+  "Generation Bio Co.": 51375,
+  "Generex Biotechnology Corporation": 50455,
+  "Genesis IBRC India Limited": 50669,
+  "Genetic Analysis AS": 50980,
+  "Genetics Generation Advancement Corp.": 50969,
+  "Genetron Holdings Limited": 51501,
+  "Genexine, Inc.": 50601,
+  "Genflow Biosciences plc": 51610,
+  "Genmab A/S": 50469,
+  "Genocea Biosciences, Inc.": 50740,
+  "Genomed Spólka Akcyjna": 50793,
+  "Genomics BioSci & Tech. Co.,Ltd.": 51071,
+  "Genomtec S.A.": 51540,
+  "Genor Biopharma Holdings Limited": 51478,
+  "Genprex, Inc.": 51039,
+  "Genus plc": 50499,
+  "GeoVax Labs, Inc.": 50647,
+  "Geron Corporation": 50426,
+  "Getein Biotech, Inc": 51077,
+  "Gilead Sciences, Inc.": 50378,
+  "Global Blood Therapeutics, Inc.": 51017,
+  "GlobeStar Therapeutics Corporation": 51276,
+  "GlycoMimetics, Inc.": 50577,
+  "GlycoNex Incorporation": 50984,
+  "Golden Biotechnology Corporation": 50833,
+  "Gongwin Biopharm Holdings Co., Ltd.": 51309,
+  "Gossamer Bio, Inc.": 51376,
+  "Grace Breeding Ltd": 51607,
+  "Gracell Biotechnologies Inc.": 51458,
+  "Graphite Bio, Inc.": 51541,
+  "Green Cross Cell Corporation": 50576,
+  "Green Cross Holdings Corporation": 50653,
+  "Greenwich LifeSciences, Inc.": 51509,
+  "Grifols, S.A.": 50478,
+  "Gritstone bio, Inc.": 51211,
+  "Guangdong Hybribio Biotech Co.,Ltd.": 51195,
+  "Guangdong VTR Bio-Tech Co., Ltd.": 50921,
+  "Guanhao Biotech Co.,Ltd.": 50906,
+  "Guard Therapeutics International AB (publ)": 51013,
+  "HAVN Life Sciences Inc.": 51524,
+  "HBM Holdings Limited": 51552,
+  "HCW Biologics Inc.": 51482,
+  "HOB Biotech Group Corp.,Ltd": 50907,
+  "HOOKIPA Pharma Inc.": 51409,
+  "HST Global, Inc.": 50801,
+  "Halberd Corporation": 50836,
+  "Halozyme Therapeutics, Inc.": 50596,
+  "Hangzhou Biotest Biotech Co.,Ltd.": 51491,
+  "HansBiomed Corporation": 50864,
+  "Hansa Biopharma AB (publ)": 50648,
+  "Harpoon Therapeutics, Inc.": 51308,
+  "Healios K.K.": 51047,
+  "Heidelberg Pharma AG": 50411,
+  "Helix BioPharma Corp.": 50488,
+  "Helixmith Co., Ltd": 50681,
+  "Hemogenyx Pharmaceuticals Plc": 51347,
+  "Hemostemix Inc.": 51053,
+  "Heron Therapeutics, Inc.": 50360,
+  "Hester Biosciences Limited": 50663,
+  "Hexima Limited": 50759,
+  "HilleVax, Inc.": 51596,
+  "Hillstream BioPharma, Inc.": 51341,
+  "Hindustan Bio Sciences Limited": 50660,
+  "Histogen Inc.": 50799,
+  "Hofseth BioCare ASA": 50974,
+  "Holy Stone Healthcare Co., Ltd.": 51080,
+  "Homology Medicines, Inc.": 51232,
+  "Horizon Therapeutics Public Limited Company": 50891,
+  "Hualan Biological Bacterin Inc.": 51144,
+  "Hualan Biological Engineering Inc.": 50651,
+  "Hubei Goto Biopharm Co.,Ltd.": 51238,
+  "Hugel, Inc.": 51042,
+  "Humacyte, Inc.": 50904,
+  "Humanigen, Inc.": 50579,
+  "I-Mab": 51499,
+  "IBEX Technologies Inc.": 50405,
+  "IDEAYA Biosciences, Inc.": 51250,
+  "IGM Biosciences, Inc.": 51213,
+  "IMV Inc.": 50593,
+  "IN8bio, Inc.": 51387,
+  "INmune Bio, Inc.": 51344,
+  "IO Biotech, Inc.": 51602,
+  "ISR Immune System Regulation Holding AB (publ)": 51318,
+  "IVERIC bio, Inc.": 50762,
+  "Icosavax, Inc.": 51472,
+  "Idogen AB (publ)": 51027,
+  "Idorsia Ltd": 51319,
+  "Imago BioSciences, Inc.": 51142,
+  "Imeik Technology Development Co.,Ltd.": 51343,
+  "Immatics N.V.": 50609,
+  "Immix Biopharma, Inc.": 51315,
+  "ImmuCell Corporation": 50381,
+  "Immune Therapeutics, Inc.": 51015,
+  "Immuneering Corporation": 51201,
+  "Immunic, Inc.": 51290,
+  "ImmunityBio, Inc.": 51187,
+  "ImmunoCellular Therapeutics, Ltd.": 50718,
+  "ImmunoGen, Inc.": 50382,
+  "Immunocore Holdings plc": 50963,
+  "Immunome, Inc.": 50908,
+  "Immunotech Biopharm Ltd": 51399,
+  "Immunovant, Inc.": 51439,
+  "Immuron Limited": 50588,
+  "Immutep Limited": 50581,
+  "Imugene Limited": 50638,
+  "Imunon, Inc.": 50430,
+  "Incyte Corporation": 50440,
+  "Indaptus Therapeutics, Inc.": 51147,
+  "Infinity Pharmaceuticals, Inc.": 50504,
+  "InflaRx N.V.": 50796,
+  "Inhibikase Therapeutics, Inc.": 50925,
+  "Inhibitor Therapeutics, Inc.": 50449,
+  "Inhibrx, Inc.": 51402,
+  "Initiator Pharma A/S": 51266,
+  "Innate Pharma S.A.": 50461,
+  "InnoCare Pharma Limited": 51500,
+  "Innovation Pharmaceuticals Inc.": 50786,
+  "Innovent Biologics, Inc.": 50977,
+  "Inovio Pharmaceuticals, Inc.": 50377,
+  "Inozyme Pharma, Inc.": 51408,
+  "Insmed Incorporated": 50383,
+  "Instil Bio, Inc.": 51493,
+  "IntegraGen SA": 50519,
+  "Intellia Therapeutics, Inc.": 51146,
+  "Intensity Therapeutics, Inc.": 51038,
+  "Intercept Pharmaceuticals, Inc.": 50640,
+  "International Stem Cell Corporation": 50736,
+  "Intervacc AB (publ)": 50940,
+  "InventisBio Co., Ltd.": 51336,
+  "Inventiva S.A.": 51137,
+  "Ionis Pharmaceuticals, Inc.": 50384,
+  "Iovance Biotherapeutics, Inc.": 50789,
+  "Iris BioTechnologies, Inc.": 50746,
+  "Ironwood Pharmaceuticals, Inc.": 50388,
+  "Isofol Medical AB (publ)": 50809,
+  "JW (Cayman) Therapeutics Co. Ltd": 51532,
+  "Jacobio Pharmaceuticals Group Co., Ltd.": 51406,
+  "Janux Therapeutics, Inc.": 51530,
+  "Japan Tissue Engineering Co., Ltd.": 50732,
+  "Jasper Therapeutics, Inc.": 51502,
+  "Jiangsu Aidea Pharmaceutical Co., Ltd.": 51329,
+  "Jiangsu CoWin Biotech Co., Ltd.": 51599,
+  "Jiangsu Recbio Technology Co., Ltd.": 51555,
+  "Jiangsu Sihuan Bioengineering Co., Ltd": 50614,
+  "Jinyu Bio-technology Co., Ltd.": 50652,
+  "Jounce Therapeutics, Inc.": 51044,
+  "Kadimastem Ltd": 51033,
+  "Kadmon Holdings, Inc.": 50930,
+  "Kainos Medicine, Inc.": 50936,
+  "KalVista Pharmaceuticals, Inc.": 50971,
+  "Kamada Ltd.": 50610,
+  "Kancera AB (publ)": 50937,
+  "Kane Biotech Inc.": 50567,
+  "Kangstem Biotech Co., Ltd.": 51117,
+  "Karuna Therapeutics, Inc.": 50967,
+  "Karyopharm Therapeutics Inc.": 50934,
+  "Kazia Therapeutics Limited": 50454,
+  "Keros Therapeutics, Inc.": 51259,
+  "Keymed Biosciences Inc.": 51585,
+  "Kezar Life Sciences, Inc.": 51192,
+  "Kiadis Pharma N.V.": 50494,
+  "Kidswell Bio Corporation": 50865,
+  "Kim Forest Enterprise Co., Ltd.": 51338,
+  "Kindred Biosciences, Inc.": 51032,
+  "Kineta, Inc.": 50877,
+  "Kiniksa Pharmaceuticals, Ltd.": 51392,
+  "Kinnate Biopharma Inc.": 51389,
+  "Kintara Therapeutics, Inc.": 50926,
+  "Kintor Pharmaceutical Limited": 50910,
+  "Kiromic BioPharma, Inc.": 51515,
+  "Kite Pharma, Inc.": 50947,
+  "KoBioLabs, Inc": 51447,
+  "Kodiak Sciences Inc.": 51235,
+  "Kolon TissueGene, Inc.": 50678,
+  "Kringle Pharma, Inc.": 50672,
+  "Kronos Bio, Inc.": 51396,
+  "Krystal Biotech, Inc.": 51348,
+  "Kura Oncology, Inc.": 51162,
+  "Kuros Biosciences AG": 50562,
+  "Kymera Therapeutics, Inc.": 51362,
+  "L&C Bio Co., Ltd": 51299,
+  "LAVA Therapeutics N.V.": 51371,
+  "LIDDS AB (publ)": 50743,
+  "La Jolla Pharmaceutical Company": 50385,
+  "LabGenomics Co., Ltd.": 50733,
+  "LadRx Corporation": 50433,
+  "Landfar Bio-medicine Co., Ltd": 50575,
+  "Lantern Pharma Inc.": 51132,
+  "Larimar Therapeutics, Inc.": 51414,
+  "Leap Therapeutics, Inc.": 50942,
+  "Legend Biotech Corporation": 51383,
+  "Lepu Biopharma Co., Ltd.": 51605,
+  "Lexicon Pharmaceuticals, Inc.": 50386,
+  "Lexston Life Sciences Corp.": 51533,
+  "LianBio": 51536,
+  "Liaoning Chengda Biotechnology Co.,Ltd.": 50844,
+  "Lifecome Biochemistry Co.,Ltd.": 50895,
+  "Liminal BioSciences Inc.": 50491,
+  "Lin BioScience, Inc.": 51388,
+  "Lineage Cell Therapeutics, Inc.": 50367,
+  "Lipella Pharmaceuticals Inc.": 50760,
+  "Lipigon Pharmaceuticals AB (publ)": 51029,
+  "Lipum AB (publ)": 51253,
+  "Lixte Biotechnology Holdings, Inc.": 50727,
+  "LogicBio Therapeutics, Inc.": 51236,
+  "Longeveron Inc.": 51305,
+  "Loxo Oncology, Inc.": 51064,
+  "Lumos Pharma, Inc.": 51096,
+  "LungLife AI, Inc.": 50850,
+  "Lyell Immunopharma, Inc.": 51435,
+  "Lysogene S.A.": 50987,
+  "Lytix Biopharma AS": 50734,
+  "MAIA Biotechnology, Inc.": 51485,
+  "MDxHealth SA": 50569,
+  "MEI Pharma, Inc.": 50530,
+  "MaaT Pharma SA": 51160,
+  "Mabion S.A.": 50916,
+  "Mabpharm Limited": 51470,
+  "Mabwell (Shanghai) Bioscience Co., Ltd.": 51520,
+  "MacroGenics, Inc.": 50467,
+  "Madrigal Pharmaceuticals, Inc.": 50989,
+  "Magenta Therapeutics, Inc.": 51303,
+  "Mainz Biomed N.V.": 51595,
+  "Manhattan Scientifics, Inc.": 50479,
+  "MannKind Corporation": 50619,
+  "Marizyme, Inc.": 50775,
+  "Marker Therapeutics, Inc.": 50526,
+  "Marvel Biosciences Corp.": 51539,
+  "Matinas BioPharma Holdings, Inc.": 51066,
+  "Matricelf Ltd": 51579,
+  "MedPacto, Inc.": 51227,
+  "Medesis Pharma S.A.": 50919,
+  "Medicenna Therapeutics Corp.": 51070,
+  "MediciNova, Inc.": 50618,
+  "Medicure Inc.": 50544,
+  "Medigen Biotechnology Corp.": 50600,
+  "Medigen Vaccine Biologics Corporation": 51189,
+  "Medigene AG": 50387,
+  "Medivir AB (publ)": 50532,
+  "Medlab Clinical Limited": 51176,
+  "Medy-Tox Inc.": 50741,
+  "MegaPro Biomedical Co., Ltd": 51407,
+  "MeiraGTx Holdings plc": 51293,
+  "Mereo BioPharma Group plc": 51200,
+  "Merrimack Pharmaceuticals, Inc.": 50523,
+  "Mersana Therapeutics, Inc.": 50522,
+  "Merus N.V.": 50703,
+  "Mesoblast Limited": 50661,
+  "Metacrine, Inc.": 51177,
+  "MiMedx Group, Inc.": 50761,
+  "MiNK Therapeutics, Inc.": 51593,
+  "Microbix Biosystems Inc.": 50389,
+  "Millendo Therapeutics, Inc.": 51006,
+  "Mineralys Therapeutics, Inc.": 51576,
+  "Minerva Neurosciences, Inc.": 51108,
+  "Mirati Therapeutics, Inc.": 50407,
+  "Mirum Pharmaceuticals, Inc.": 51434,
+  "Modalis Therapeutics Corporation": 51373,
+  "Moderna, Inc.": 50951,
+  "Modus Therapeutics Holding AB (publ)": 51577,
+  "Molecular Partners AG": 50742,
+  "Molecular Templates, Inc.": 50720,
+  "Moleculin Biotech, Inc.": 51226,
+  "Monopar Therapeutics Inc.": 51193,
+  "Monte Rosa Therapeutics, Inc.": 51544,
+  "MoonLake Immunotherapeutics": 51580,
+  "Morphic Holding, Inc.": 51274,
+  "MorphoSys AG": 50413,
+  "Mustang Bio, Inc.": 51247,
+  "Mycenax Biotech Inc.": 50821,
+  "Mymetics Corporation": 50513,
+  "Myovant Sciences Ltd.": 51291,
+  "Myriad Genetics, Inc.": 50390,
+  "NFL Biosciences SA": 51531,
+  "NKGen Biotech, Inc.": 51446,
+  "NanoLogix, Inc.": 50496,
+  "NanoViricides, Inc.": 50683,
+  "Nanobiotix S.A.": 50670,
+  "Nanollose Limited": 51349,
+  "Nanologica AB (publ)": 50973,
+  "Nascent Biotech, Inc.": 51130,
+  "Natera, Inc.": 50717,
+  "Navidea Biopharmaceuticals, Inc.": 50438,
+  "NeoImmuneTech, Inc.": 51157,
+  "Neoleukin Therapeutics, Inc.": 50756,
+  "Neovacs S.A.": 50578,
+  "NeuBase Therapeutics, Inc.": 51448,
+  "Neumora Therapeutics, Inc.": 51600,
+  "NeuroBo Pharmaceuticals, Inc.": 51484,
+  "NeuroScientific Biopharmaceuticals Limited": 51357,
+  "NeuroSense Therapeutics Ltd.": 51381,
+  "Neurocrine Biosciences, Inc.": 50391,
+  "NexImmune, Inc.": 50990,
+  "NextCell Pharma AB": 51179,
+  "NextCure, Inc.": 51231,
+  "Nextage Therapeutics Ltd": 51486,
+  "Nicox S.A.": 50410,
+  "Nkarta, Inc.": 51365,
+  "Noile-Immune Biotech Inc.": 51351,
+  "Nordic Nanovector ASA": 50939,
+  "Northwest Biotherapeutics, Inc.": 50512,
+  "NovAccess Global Inc.": 50546,
+  "Nova Mentis Life Science Corp.": 50719,
+  "Novacyt S.A.": 50817,
+  "Novartis Gene Therapies, Inc.": 51104,
+  "Novavax, Inc.": 50444,
+  "Novelion Therapeutics Inc.": 50437,
+  "Noxopharm Limited": 51275,
+  "NuCana plc": 50823,
+  "Nurix Therapeutics, Inc.": 51011,
+  "Nutra Pharma Corp.": 50520,
+  "Nuvalent, Inc.": 51567,
+  "Nuvectis Pharma, Inc.": 51594,
+  "Nykode Therapeutics AS": 50858,
+  "Nymox Pharmaceutical Corporation": 50452,
+  "OBI Pharma, Inc.": 50755,
+  "OKYO Pharma Limited": 50805,
+  "ORIC Pharmaceuticals, Inc.": 51188,
+  "OSE Immunotherapeutics SA": 51031,
+  "ObsEva SA": 51068,
+  "Ocugen, Inc.": 51190,
+  "Olema Pharmaceuticals, Inc.": 51359,
+  "Omega Therapeutics, Inc.": 51463,
+  "Oncimmune Holdings plc": 50798,
+  "OncoCyte Corporation": 50872,
+  "OncoSec Medical Incorporated": 50812,
+  "OncoTherapy Science, Inc.": 50615,
+  "Oncodesign Société Anonyme": 50472,
+  "Oncolys BioPharma Inc.": 50758,
+  "Oncolytics Biotech Inc.": 50511,
+  "Oncopeptides AB (publ)": 50654,
+  "Oncorus, Inc.": 51255,
+  "Oncotelic Therapeutics, Inc.": 51242,
+  "Oncternal Therapeutics, Inc.": 51273,
+  "OpGen, Inc.": 50506,
+  "Opthea Limited": 50533,
+  "OptiBiotix Health Plc": 50957,
+  "Oragenics, Inc.": 50483,
+  "Orchard Therapeutics plc": 51264,
+  "Organicell Regenerative Medicine, Inc.": 51023,
+  "Organogenesis Holdings Inc.": 50436,
+  "Organovo Holdings, Inc.": 50900,
+  "Orgenesis Inc.": 50839,
+  "Orphazyme A/S": 50885,
+  "Orthocell Limited": 50837,
+  "Oryzon Genomics S.A.": 50538,
+  "Outlook Therapeutics, Inc.": 50992,
+  "Ovid Therapeutics Inc.": 51174,
+  "Oxford Biomedica plc": 50468,
+  "Oxurion NV": 50487,
+  "Oyster Point Pharma, Inc.": 51360,
+  "PCI Biotech Holding ASA": 50803,
+  "PDS Biotechnology Corporation": 50835,
+  "PMV Pharmaceuticals, Inc.": 51106,
+  "POINT Biopharma Global Inc.": 51512,
+  "PTC Therapeutics, Inc.": 50498,
+  "PYC Therapeutics Limited": 50677,
+  "Pacific Edge Limited": 50635,
+  "Pacific Shuanglin Bio-pharmacy Co., LTD": 50573,
+  "Paion AG": 50536,
+  "Palatin Technologies, Inc.": 50392,
+  "Panacea Biotec Limited": 50608,
+  "Panbela Therapeutics, Inc.": 51000,
+  "Paradigm Biopharmaceuticals Limited": 51145,
+  "Pardes Biosciences, Inc.": 51566,
+  "Pasithea Therapeutics Corp.": 51569,
+  "Passage Bio, Inc.": 51456,
+  "Patrys Limited": 50757,
+  "PeopleBio, Inc.": 50731,
+  "PepGen Inc.": 51591,
+  "PeptiDream Inc.": 50863,
+  "Perseus Proteomics Inc.": 50710,
+  "PharmAbcine Inc.": 50868,
+  "Pharma Foods International Co., Ltd.": 50694,
+  "Pharma Mar, S.A.": 50421,
+  "PharmaCyte Biotech, Inc.": 50554,
+  "PharmaEngine, Inc.": 50701,
+  "PharmaEssentia Corporation": 50849,
+  "PharmaLundensis AB": 50899,
+  "PharmaResearch Co., Ltd.": 51052,
+  "Pharming Group N.V.": 50393,
+  "Pharnext SA": 50785,
+  "PhaseBio Pharmaceuticals, Inc.": 50555,
+  "Pherecydes Pharma Société anonyme": 51084,
+  "Philogen S.p.A.": 50711,
+  "Phio Pharmaceuticals Corp.": 50975,
+  "Pieris Pharmaceuticals, Inc.": 50521,
+  "Plant Advanced Technologies SA": 50859,
+  "Plus Therapeutics, Inc.": 50432,
+  "Polaris Group": 51237,
+  "Poltreg S.A.": 51452,
+  "Polyphor AG": 50503,
+  "Portage Biotech Inc.": 51046,
+  "Poseida Therapeutics, Inc.": 51186,
+  "Poxel S.A.": 50912,
+  "Praxis Precision Medicines, Inc.": 51301,
+  "Precigen, Inc.": 50680,
+  "Precision BioSciences, Inc.": 50790,
+  "Predictive Technology Group, Inc.": 50737,
+  "Predilife S.A.": 51442,
+  "Prelude Therapeutics Incorporated": 51280,
+  "Prescient Therapeutics Limited": 50565,
+  "Prestige BioPharma Limited": 51326,
+  "Prevail Therapeutics Inc.": 51386,
+  "Prime Medicine, Inc.": 51590,
+  "ProKidney Corp.": 51450,
+  "ProMIS Neurosciences, Inc.": 50646,
+  "ProQR Therapeutics N.V.": 51028,
+  "ProText Mobility, Inc.": 51311,
+  "Probi AB (publ)": 50502,
+  "Prometheus Biosciences, Inc.": 51358,
+  "Promore Pharma AB (publ)": 51294,
+  "Propanc Biopharma, Inc.": 50970,
+  "Prostatype Genomics AB (publ)": 51517,
+  "Protagenic Therapeutics, Inc.": 50964,
+  "Protagonist Therapeutics, Inc.": 50956,
+  "Protalix BioTherapeutics, Inc.": 50495,
+  "Protara Therapeutics, Inc.": 51368,
+  "Prothena Corporation plc": 51021,
+  "ProtoKinetix, Incorporated": 50592,
+  "Psomagen, Inc.": 51320,
+  "PsyBio Therapeutics Corp.": 51521,
+  "Psyence Group Inc.": 51535,
+  "Puma Biotechnology, Inc.": 50953,
+  "PureTech Health plc": 50617,
+  "Pyxis Oncology, Inc.": 51483,
+  "Q BioMed Inc.": 51092,
+  "QSAM Biosciences, Inc.": 50894,
+  "Qingdao Vland Biotech INC.": 51171,
+  "Qrons Inc.": 51298,
+  "Qualigen Therapeutics, Inc.": 50517,
+  "QuantaMatrix Inc.": 51170,
+  "Quantum Genomics Société Anonyme": 50682,
+  "Quest PharmaTech Inc.": 50525,
+  "QuiaPEG Pharmaceuticals Holding AB (publ)": 50475,
+  "Quince Therapeutics, Inc.": 51123,
+  "Quoin Pharmaceuticals, Ltd.": 51440,
+  "Qurient Co., Ltd.": 50933,
+  "RAPT Therapeutics, Inc.": 51139,
+  "REGENXBIO Inc.": 50960,
+  "RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.": 51119,
+  "Race Oncology Limited": 51267,
+  "Radiopharm Theranostics Limited": 51603,
+  "Radius Health, Inc.": 50627,
+  "Rakovina Therapeutics Inc.": 51523,
+  "Rallybio Corporation": 51588,
+  "Raphael Pharmaceutical Inc.": 51587,
+  "Rasna Therapeutics, Inc.": 51285,
+  "RayzeBio, Inc.": 51548,
+  "ReNeuron Group plc": 50409,
+  "Read-Gene S.A.": 50829,
+  "Rebus Holdings, Inc.": 50816,
+  "Recursion Pharmaceuticals, Inc.": 51110,
+  "Regen BioPharma, Inc.": 51009,
+  "RegeneRx Biopharmaceuticals, Inc.": 50427,
+  "Regeneron Pharmaceuticals, Inc.": 50395,
+  "Regeneus Ltd": 51067,
+  "Regenicin, Inc.": 50776,
+  "Regulus Therapeutics Inc.": 50767,
+  "Relay Therapeutics, Inc.": 51288,
+  "Relief Therapeutics Holding AG": 51143,
+  "RemeGen Co., Ltd.": 51551,
+  "Reneo Pharmaceuticals, Inc.": 51149,
+  "RenovaCare, Inc.": 50543,
+  "Renovacor, Inc.": 51488,
+  "RenovoRx, Inc.": 51050,
+  "Repare Therapeutics Inc.": 51340,
+  "Replimune Group, Inc.": 51410,
+  "ReproCELL Incorporated": 50764,
+  "Respiratorius AB (publ)": 50716,
+  "Resverlogix Corp.": 50539,
+  "Reunion Neuroscience Inc.": 51510,
+  "Revelation Biosciences, Inc.": 51557,
+  "Revolution Medicines, Inc.": 51167,
+  "Rezolute, Inc.": 50998,
+  "RhoVac AB": 51234,
+  "Rhythm Pharmaceuticals, Inc.": 51202,
+  "Ribomic Inc.": 50810,
+  "Rich Pharmaceuticals, Inc.": 50961,
+  "Rigel Pharmaceuticals, Inc.": 50396,
+  "Rocket Pharmaceuticals, Inc.": 51330,
+  "Roivant Sciences Ltd.": 51161,
+  "Roquefort Therapeutics plc": 51553,
+  "Rubius Therapeutics, Inc.": 51220,
+  "SAB Biotherapeutics, Inc.": 51128,
+  "SELLAS Life Sciences Group, Inc.": 51113,
+  "SK bioscience Co.,Ltd.": 51419,
+  "SQZ Biotechnologies Company": 51111,
+  "Sage Therapeutics, Inc.": 50982,
+  "Sagimet Biosciences Inc.": 50753,
+  "Salarius Pharmaceuticals, Inc.": 51252,
+  "SanBio Company Limited": 51138,
+  "Sana Biotechnology, Inc.": 51449,
+  "Sangamo Therapeutics, Inc.": 50458,
+  "Sangui Biotech International, Inc.": 50548,
+  "Saniona AB (publ)": 51105,
+  "Santhera Pharmaceuticals Holding AG": 50643,
+  "Sarepta Therapeutics, Inc.": 50447,
+  "Satellos Bioscience Inc.": 51505,
+  "Savara Inc.": 50842,
+  "Scancell Holdings plc": 50463,
+  "Scandion Oncology A/S": 51372,
+  "Scholar Rock Holding Corporation": 51377,
+  "SciSparc Ltd.": 50690,
+  "Scopus BioPharma Inc.": 51476,
+  "Seagen Inc.": 50397,
+  "Seegene, Inc.": 50620,
+  "Selecta Biosciences, Inc.": 50832,
+  "Senhwa Biosciences, Inc.": 51085,
+  "Sensei Biotherapeutics, Inc.": 50477,
+  "Sensorion SA": 51005,
+  "Senti Biosciences, Inc.": 51355,
+  "SenzaGen AB": 51154,
+  "Seoulin Bioscience Co.,Ltd.": 50699,
+  "Sera Prognostics, Inc.": 50941,
+  "Seres Therapeutics, Inc.": 51025,
+  "Sernova Corp.": 50473,
+  "Sesen Bio, Inc.": 50882,
+  "Shandong Kexing Bioproducts Co,.Ltd": 50903,
+  "Shanghai Haohai Biological Technology Co., Ltd.": 50909,
+  "Shanghai Henlius Biotech, Inc.": 51056,
+  "Shanghai Junshi Biosciences Co., Ltd.": 51203,
+  "Shanghai MicuRx Pharmaceutical Co., Ltd.": 51606,
+  "Shanghai OPM Biosciences Co., Ltd.": 51361,
+  "Shanghai RAAS Blood Products Co., Ltd.": 50769,
+  "Shanghai Rightongene Biotechnology Co., Ltd.": 51527,
+  "Shanghai Serum Bio-Technology Co., Ltd.": 51010,
+  "Shaperon Inc.": 51401,
+  "Shattuck Labs, Inc.": 51282,
+  "Shenzhen Kangtai Biological Products Co., Ltd.": 50854,
+  "Shenzhen Weiguang Biological Products Co., Ltd.": 50848,
+  "Shuttle Pharmaceuticals Holdings, Inc.": 51225,
+  "Sierra Oncology, Inc.": 50631,
+  "Sigilon Therapeutics, Inc.": 51339,
+  "Silence Therapeutics plc": 50423,
+  "SillaJen, Inc.": 51058,
+  "Silo Pharma, Inc.": 50955,
+  "Silverback Therapeutics, Inc.": 51256,
+  "Sino Biological,Inc.": 51045,
+  "SinoMab BioScience Limited": 50888,
+  "Sinocelltech Group Limited": 51416,
+  "Sinovac Biotech Ltd.": 50585,
+  "Sio Gene Therapies Inc.": 51183,
+  "Sirnaomics Ltd.": 51608,
+  "Sirona Biochem Corp.": 50745,
+  "SkinBioTherapeutics Plc": 51292,
+  "Skye Bioscience, Inc.": 51125,
+  "Smart Agro - Limited": 51549,
+  "Solasia Pharma K.K.": 50770,
+  "Soleno Therapeutics, Inc.": 50534,
+  "Solid Biosciences Inc.": 51215,
+  "Soligenix, Inc.": 50372,
+  "Sonnet BioTherapeutics Holdings, Inc.": 51304,
+  "Sorrento Therapeutics, Inc.": 50846,
+  "Spago Nanomedical AB (publ)": 50818,
+  "Spark Therapeutics, Inc.": 51079,
+  "Spectral Medical Inc.": 50398,
+  "Spectrum Pharmaceuticals, Inc.": 50450,
+  "Spero Therapeutics, Inc.": 51054,
+  "Spexis AG": 51133,
+  "SpringWorks Therapeutics, Inc.": 51465,
+  "Sprint Bioscience AB (publ)": 50922,
+  "Spruce Biosciences, Inc.": 51316,
+  "StageZero Life Sciences Ltd.": 50542,
+  "Statera Biopharma, Inc.": 51116,
+  "Stealth BioTherapeutics Corp": 50822,
+  "Stem Cells Spin S.A.": 50913,
+  "StemRIM": 51481,
+  "Stoke Therapeutics, Inc.": 51081,
+  "Summit Therapeutics Inc.": 50644,
+  "SunBio,Inc.": 50702,
+  "Sunmax Biotechnology Co., Ltd.": 50834,
+  "Sunshine Biopharma, Inc.": 50873,
+  "Surface Oncology, Inc.": 51159,
+  "Surrozen, Inc.": 51289,
+  "Sutro Biopharma, Inc.": 50779,
+  "Suzhou Zelgen Biopharmaceuticals Co., Ltd.": 51281,
+  "Swedish Orphan Biovitrum AB (publ)": 50501,
+  "SynAct Pharma AB": 51260,
+  "Synairgen plc": 50662,
+  "Synaptogenix, Inc.": 51129,
+  "Syndax Pharmaceuticals, Inc.": 50714,
+  "Synlogic, Inc.": 51127,
+  "Syros Pharmaceuticals, Inc.": 51051,
+  "T2 Biosystems, Inc.": 50735,
+  "TC Biopharm (Holdings) Plc": 51598,
+  "TCM Biotech International Corp.": 51008,
+  "TCR2 Therapeutics Inc.": 51217,
+  "TG Therapeutics, Inc.": 50986,
+  "TME Pharma N.V.": 50420,
+  "TOT BIOPHARM International Company Limited": 51498,
+  "TRACON Pharmaceuticals, Inc.": 50748,
+  "TScan Therapeutics, Inc.": 51427,
+  "TWi Biotechnology, Inc.": 51102,
+  "TaiGen Biopharmaceuticals Holdings Limited": 51069,
+  "TaiMed Biologics Inc.": 50881,
+  "TaiRx, Inc.": 51214,
+  "Taiwan Liposome Company, Ltd.": 50806,
+  "TaiwanJ Pharmaceuticals Co., Ltd.": 51198,
+  "Takara Bio Inc.": 50556,
+  "Talaris Therapeutics, Inc.": 51466,
+  "Tango Therapeutics, Inc.": 51327,
+  "Tanvex BioPharma, Inc.": 51196,
+  "Taysha Gene Therapies, Inc.": 51519,
+  "TegoScience Inc.": 50726,
+  "Telix Pharmaceuticals Limited": 51353,
+  "Telo Genomics Corp.": 51221,
+  "Tempest Therapeutics, Inc.": 51382,
+  "Tenax Therapeutics, Inc.": 50453,
+  "Tenaya Therapeutics, Inc.": 51300,
+  "Tengion, Inc.": 50632,
+  "Thalys Medical Technology Group Corporation": 50993,
+  "TheraVet SA": 51538,
+  "Theralink Technologies, Inc.": 51194,
+  "Theratechnologies Inc.": 50482,
+  "Theriva Biologics, Inc.": 50698,
+  "Tissue Regenix Group plc": 50739,
+  "Tissue Repair Ltd": 51601,
+  "Tiziana Life Sciences Ltd": 51109,
+  "Todos Medical Ltd.": 51248,
+  "Toleranzia AB": 51043,
+  "Tonix Pharmaceuticals Holding Corp.": 50918,
+  "ToolGen Incorporated": 50510,
+  "Trans Genic Inc.": 50613,
+  "TransCode Therapeutics, Inc.": 51370,
+  "Transcenta Holding Limited": 51471,
+  "Transgene Biotek Limited": 50664,
+  "Transgene SA": 50451,
+  "Translate Bio, Inc.": 50988,
+  "Travere Therapeutics, Inc.": 50966,
+  "Trevena, Inc.": 50792,
+  "TriSalus Life Sciences, Inc.": 50945,
+  "Trillium Therapeutics Inc.": 50649,
+  "Turning Point Therapeutics, Inc.": 51088,
+  "Turnstone Biologics Corp.": 51454,
+  "Twist Bioscience Corporation": 51065,
+  "Tyme Technologies, Inc.": 51173,
+  "Tyra Biosciences, Inc.": 51507,
+  "U.S. Stem Cell, Inc.": 50480,
+  "UBI Pharma Inc.": 51240,
+  "Ultimovacs ASA": 51061,
+  "Ultragenyx Pharmaceutical Inc.": 50938,
+  "Uni-Bio Science Group Limited": 50633,
+  "UnicoCell Biomed Co., Ltd.": 51560,
+  "Unicycive Therapeutics, Inc.": 51460,
+  "United Therapeutics Corporation": 50399,
+  "Unity Biotechnology, Inc.": 51241,
+  "Univo Pharmaceuticals Ltd": 51394,
+  "Unum Therapeutics Inc.": 51140,
+  "UroGen Pharma Ltd.": 51057,
+  "Urteste S.A.": 51586,
+  "VBI Vaccines Inc.": 51175,
+  "Vaccinex, Inc.": 50637,
+  "Vaccitech plc": 51278,
+  "Valbiotis SA": 51271,
+  "ValiRx plc": 50723,
+  "Valneva SE": 50568,
+  "Vanda Pharmaceuticals Inc.": 50700,
+  "Vascular Biogenics Ltd.": 50558,
+  "Vaxart, Inc.": 50774,
+  "Vaxcyte, Inc.": 51199,
+  "Vaxil Bio Ltd.": 50905,
+  "Vaxxinity, Inc.": 51574,
+  "Vcanbio Cell & Gene Engineering Corp., Ltd": 50650,
+  "VectivBio Holding AG": 51575,
+  "Vectus Biosystems Limited": 51218,
+  "Vera Therapeutics, Inc.": 51537,
+  "Veracyte, Inc.": 50794,
+  "Verastem, Inc.": 50935,
+  "Vericel Corporation": 50358,
+  "Verici Dx plc": 51518,
+  "Vertex Pharmaceuticals Incorporated": 50400,
+  "Verve Therapeutics, Inc.": 51469,
+  "ViGenCell Inc.": 51429,
+  "Vicapsys Life Sciences, Inc.": 51374,
+  "Vicore Pharma Holding AB (publ)": 50515,
+  "Vigil Neuroscience, Inc.": 51545,
+  "Viking Therapeutics, Inc.": 51072,
+  "Vincerx Pharma, Inc.": 51543,
+  "Vir Biotechnology, Inc.": 51322,
+  "Viracta Therapeutics, Inc.": 50778,
+  "Viridian Therapeutics, Inc.": 50802,
+  "Virios Therapeutics, Inc.": 51007,
+  "Vistagen Therapeutics, Inc.": 50591,
+  "VitaSpring Biomedical Co. Ltd.": 51324,
+  "Vitro Biopharma, Inc.": 50493,
+  "Vitrolife AB (publ)": 50485,
+  "Vivesto AB": 50671,
+  "Vivoryon Therapeutics N.V.": 50417,
+  "Vor Biopharma Inc.": 51412,
+  "Voronoi, Inc.": 51424,
+  "Voyager Therapeutics, Inc.": 51100,
+  "Vyant Bio, Inc.": 51219,
+  "WPD Pharmaceuticals Inc.": 51462,
+  "Walvax Biotechnology Co., Ltd.": 50856,
+  "Waverley Pharma Inc.": 51346,
+  "Werewolf Therapeutics, Inc.": 51397,
+  "Willow Biosciences Inc.": 51352,
+  "Windtree Therapeutics, Inc.": 50371,
+  "WntResearch AB": 50928,
+  "Wuhan Hiteck Biological Pharma Co.,Ltd": 51158,
+  "X4 Pharmaceuticals, Inc.": 51165,
+  "XBiotech Inc.": 51024,
+  "XOMA Corporation": 50401,
+  "XTL Biopharmaceuticals Ltd.": 50402,
+  "Xbrane Biopharma AB (publ)": 50962,
+  "Xencor, Inc.": 50481,
+  "Xenetic Biosciences, Inc.": 50684,
+  "Xenon Pharmaceuticals Inc.": 50466,
+  "Xiamen Amoytop Biotech Co., Ltd.": 51041,
+  "Xilio Therapeutics, Inc.": 51277,
+  "Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.": 51004,
+  "Xintela AB (publ)": 51076,
+  "Xspray Pharma AB (publ)": 51335,
+  "Y-mAbs Therapeutics, Inc.": 51283,
+  "Yantai Dongcheng Pharmaceutical Group Co.,Ltd.": 50819,
+  "Yantai Zhenghai Biotechnology Co., Ltd.": 51212,
+  "Yield10 Bioscience, Inc.": 50560,
+  "Yili Chuannig Biotechnology Co., Ltd.": 51492,
+  "Yubo International Biotech Limited": 51565,
+  "Yumanity Therapeutics Inc.": 51181,
+  "Zai Lab Limited": 51131,
+  "Zealand Pharma A/S": 50507,
+  "Zenith Capital Corp.": 51059,
+  "Zenotech Laboratories Limited": 50666,
+  "Zentalis Pharmaceuticals, Inc.": 51503,
+  "Zhejiang Orient Gene Biotech Co., Ltd.": 51496,
+  "ZyVersa Therapeutics, Inc.": 51126,
+  "Zymeworks Inc.": 50797,
+  "aTyr Pharma, Inc.": 50749,
+  "argenx SE": 50862,
+  "bioAffinity Technologies, Inc.": 51325,
+  "bluebird bio, Inc.": 50376,
+  "co.don AG": 50422,
+  "e-therapeutics plc": 50685,
+  "eFFECTOR Therapeutics, Inc.": 51055,
+  "genOway Société anonyme": 50414,
+  "genXone S.A.": 51428,
+  "iBio, Inc.": 50394,
+  "iTeos Therapeutics, Inc.": 51516,
+  "uniQure N.V.": 50996,
+  "vTv Therapeutics Inc.": 51191
+}

config.json

@@ -0,0 +1,34 @@
+{
+  "_name_or_path": "google/bigbird-roberta-base",
+  "architectures": [
+    "BigBirdForMaskedLM"
+  ],
+  "attention_probs_dropout_prob": 0.1,
+  "attention_type": "block_sparse",
+  "block_size": 64,
+  "bos_token_id": 1,
+  "classifier_dropout": null,
+  "eos_token_id": 2,
+  "gradient_checkpointing": false,
+  "hidden_act": "gelu_new",
+  "hidden_dropout_prob": 0.1,
+  "hidden_size": 768,
+  "initializer_range": 0.02,
+  "intermediate_size": 3072,
+  "layer_norm_eps": 1e-12,
+  "max_position_embeddings": 4096,
+  "model_type": "big_bird",
+  "num_attention_heads": 12,
+  "num_hidden_layers": 12,
+  "num_random_blocks": 3,
+  "pad_token_id": 0,
+  "position_embedding_type": "absolute",
+  "rescale_embeddings": false,
+  "sep_token_id": 66,
+  "torch_dtype": "float32",
+  "transformers_version": "4.34.1",
+  "type_vocab_size": 2,
+  "use_bias": true,
+  "use_cache": true,
+  "vocab_size": 51614
+}

generation_config.json

@@ -0,0 +1,7 @@
+{
+  "_from_model_config": true,
+  "bos_token_id": 1,
+  "eos_token_id": 2,
+  "pad_token_id": 0,
+  "transformers_version": "4.34.1"
+}

pytorch_model.bin

@@ -0,0 +1,3 @@
+version https://git-lfs.github.com/spec/v1
+oid sha256:639bd28d67f89252943a64be5a34399c65880aafc7b46445b53e9adf7064e16c
+size 516378618

special_tokens_map.json

@@ -0,0 +1,51 @@
+{
+  "bos_token": {
+    "content": "</s>",
+    "lstrip": false,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  },
+  "cls_token": {
+    "content": "[CLS]",
+    "lstrip": false,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  },
+  "eos_token": {
+    "content": "<s>",
+    "lstrip": false,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  },
+  "mask_token": {
+    "content": "[MASK]",
+    "lstrip": true,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  },
+  "pad_token": {
+    "content": "<pad>",
+    "lstrip": false,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  },
+  "sep_token": {
+    "content": "[SEP]",
+    "lstrip": false,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  },
+  "unk_token": {
+    "content": "<unk>",
+    "lstrip": false,
+    "normalized": true,
+    "rstrip": false,
+    "single_word": false
+  }
+}

spiece.model

@@ -0,0 +1,3 @@
+version https://git-lfs.github.com/spec/v1
+oid sha256:fdc81e1fc9d42e0c08b86d5b280d05d7c5e9747c4231c648f2b56b8e1d893c82
+size 845731